Six weeks of GLP-1 infusion resulted in significant improvements in fasting (decrease of 4.3 mM glucose) and 8 h mean glucose (decrease of 5.5 mM), fasting and mean 8h free fatty acids, a reduction in HbA1c from 9.2% to 7.9%, a decrease in fructosamine from 349 uM to 282 uM, and a reduction in gastric emptying 3,4
Cheng, M.S
GLP-1 maintains glucose levels by stimulating pancreatic cells to produce insulin, slowing gastric emptying, and decreasing glucagon release 4
"When you think about normalizing obesity and the treatment of it, people are used to taking a pill for hypertension or for high cholesterol, so here's another way that it just normalizes it to take a pill for a condition that we know is a chronic disease," Narula said
doi: 10.1016/j.jneumeth.2005.04.011 50 KrohnF.NovelloM.van der GiessenR
Verify current status directly with FDA.gov before any clinical use